Seng Gee Lim

1993–2025 年に発表

107
論文数
21,735
被引用数
71
h 指数
103
i10 指数

被引用数

Seng Gee Lim の年別被引用数1966 年: 被引用 1 件1979 年: 被引用 1 件1995 年: 被引用 6 件1996 年: 被引用 2 件1997 年: 被引用 2 件1998 年: 被引用 6 件1999 年: 被引用 7 件2000 年: 被引用 4 件2001 年: 被引用 13 件2002 年: 被引用 12 件2003 年: 被引用 61 件2004 年: 被引用 81 件2005 年: 被引用 112 件2006 年: 被引用 101 件2007 年: 被引用 144 件2008 年: 被引用 121 件2009 年: 被引用 142 件2010 年: 被引用 110 件2011 年: 被引用 132 件2012 年: 被引用 158 件2013 年: 被引用 100 件2014 年: 被引用 149 件2015 年: 被引用 134 件2016 年: 被引用 122 件2017 年: 被引用 136 件2018 年: 被引用 129 件2019 年: 被引用 526 件2020 年: 被引用 703 件2021 年: 被引用 762 件2022 年: 被引用 525 件2023 年: 被引用 396 件2024 年: 被引用 727 件2025 年: 被引用 293 件2026 年: 被引用 8 件1967〜1978 年は被引用が無いため表示していません1980〜1994 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 1,504 件、この内訳の 17.3%中国: 引用元論文 1,469 件、この内訳の 16.9%イギリス: 引用元論文 404 件、この内訳の 4.7%ドイツ: 引用元論文 370 件、この内訳の 4.3%台湾: 引用元論文 346 件、この内訳の 4%フランス: 引用元論文 331 件、この内訳の 3.8%韓国: 引用元論文 307 件、この内訳の 3.5%イタリア: 引用元論文 299 件、この内訳の 3.4%日本: 引用元論文 297 件、この内訳の 3.4%シンガポール: 引用元論文 269 件、この内訳の 3.1%カナダ: 引用元論文 267 件、この内訳の 3.1%インド: 引用元論文 261 件、この内訳の 3%
0%17.3%その他 29.5%

分野

  • Medicine81.5%
  • Biochemistry, Genetics and Molecular Biology8.8%
  • Immunology and Microbiology4.9%
  • Pharmacology, Toxicology and Pharmaceutics1.9%
  • Agricultural and Biological Sciences0.7%
  • Engineering0.4%
  • その他1.8%

トピック

  • Hepatitis B Virus Studies13.8%
  • Hepatitis C virus research11.8%
  • Liver Disease Diagnosis and Treatment10.3%
  • Hepatitis Viruses Studies and Epidemiology4.5%
  • Liver Disease and Transplantation4.5%
  • Hepatocellular Carcinoma Treatment and Prognosis3.7%
  • その他51.4%

共著者

全論文

検索で開く
  1. Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Man‐Fung Yuen, Shu Zheng, Jia‐Horng Kao - Hepatology International 2015 被引用: 2,564

  2. Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific association for the study of the liver (APASL): an update

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Omesh Goyal, Hasmik Ghazinyan, Anil Arora, Jinhua Hu, Manoj Kumar Sahu, Padaki Nagaraja Rao, Guan Huei Lee, Seng Gee Lim, Laurentius A. Lesmana, Cosmas Rinaldi Adithya Lesmana, Samir Shah, V. G. Mohan Prasad, Diana A. Payawal, Zaigham Abbas, A. Kadir Dökmeci, Jose D. Sollano, Gian Carpio, Ananta Shresta, George Lau, Md. Fazal Karim, Gamal Shiha, Rino Alvani Gani, Kemal Fariz Kalista, Man‐Fung Yuen, Bikrant Bihari Lal, Rajeev Khanna, Vikrant Sood, Bikrant Bihari Lal, Viniyendra Pamecha, Ankur Jindal, V. Rajan, Vinod Arora, Osamu Yokosuka, Madunil Anuk Niriella, Hai Li, Xiaolong Qi, Atsushi Tanaka, Satoshi Mochida, Dominic Ray Chaudhuri, Ed Gane, Khin Maung Win, Wei Ting Chen, M Rela, Dharmesh Kapoor, Amit Rastogi, Pratibha Kale, Archana Rastogi, Chhagan Bihari Sharma, Meenu Bajpai, Virender Singh, Madhumita Premkumar, Sudhir Maharashi, A. Olithselvan, Cyriac Abby Philips, Anshu Srivastava, Surender Kumar Yachha, Zeeshan Ahmad Wani, B. R. Thapa, Anoop Saraya, S. Shalimar, Ashish Kumar, Manav Wadhawan, Subash Gupta, Kaushal Madan, Puja Sakhuja, Vivek Vij, Barjesh Chander Sharma, Hitendra Garg, Vishal Garg, Chetan Kalal ほか 12 名 - Hepatology International 2019 被引用: 889

  3. Liver diseases in the Asia-Pacific region: a Lancet Gastroenterology & Hepatology Commission

    著者: , , , , , , , , , , , , , , , , , , , - ˜The œLancet. Gastroenterology & hepatology 2019 被引用: 524

  4. Efficacy and Safety of Bepirovirsen in Chronic Hepatitis B Infection

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Helene Plein, Fiona Campbell, Melanie Paff, Dickens Theodore - New England Journal of Medicine 2022 被引用: 252

  5. A global scientific strategy to cure hepatitis B

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , William Mason, Gail Matthews, Dimitrios Paraskevis, Jörg Petersen, Barbara Rehermann, Eui‐Cheol Shin, Alexander Thompson, Florian van Bömmel, Fusheng Wang, Koichi Watashi, Hung‐Chih Yang, Zhenghong Yuan, Man‐Fung Yuen, Timothy M. Block, Veronica Miller, Ulrike Protzer, Christian Bréchot, Stephen Locarnini, Marion G. Peters, Raymond F. Schinazi, Fabien Zoulim - ˜The œLancet. Gastroenterology & hepatology 2019 被引用: 495

  6. The scientific basis of combination therapy for chronic hepatitis B functional cure

    著者: , , , , , , , , - Nature Reviews Gastroenterology & Hepatology 2023 被引用: 156

  7. Non-terminally exhausted tumor-resident memory HBV-specific T cell responses correlate with relapse-free survival in hepatocellular carcinoma

    著者: , , , , , , , , , , , , , , , , , , , , , , , , - Immunity 2021 被引用: 136

  8. Antiviral therapy substantially reduces HCC risk in patients with chronic hepatitis B infection in the indeterminate phase

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Ramsey Cheung, Seng Gee Lim, Huy N. Trinh, Wan‐Long Chuang, Yasuhito Tanaka, Hidenori Toyoda, Ming‐Lung Yu, Mindie H. Nguyen - Hepatology 2023 被引用: 89

  9. Chronic Infection With Camelid Hepatitis E Virus in a Liver Transplant Recipient Who Regularly Consumes Camel Meat and Milk

    著者: , , , , , , , , , , , - Gastroenterology 2015 被引用: 550

  10. Evaluation of APRI and FIB-4 scoring systems for non-invasive assessment of hepatic fibrosis in chronic hepatitis B patients

    著者: , , , , , , , , , , , , , , , , , , - Journal of Hepatology 2015 被引用: 291

  11. Development of a new patient-derived xenograft humanised mouse model to study human-specific tumour microenvironment and immunotherapy

    著者: , , , , , , , , , , , , , , , , , , , , , , - Gut 2018 被引用: 207

  12. CD4+ T Cells Mediate the Development of Liver Fibrosis in High Fat Diet-Induced NAFLD in Humanized Mice

    著者: , , , , , , , , , , , , , , , , , , , , , , - Frontiers in Immunology 2020 被引用: 97

  13. CpG-Adjuvanted Hepatitis B Vaccine (HEPLISAV-B®) Update

    著者: , - Expert Review of Vaccines 2021 被引用: 99

  14. Drug-Induced Acute-on-Chronic Liver Failure in Asian Patients

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , L.A. Lesmana, Cosmas Rinaldi Adithya Lesmana, Samir Shah, Chetan Kalal, Zaigham Abbas, Jose D. Sollano, V. G. Mohan Prasad, Diana Payawal, A. Kadir Dökmeci, Padaki Nagaraja Rao, Ananta Shrestha, George Lau, Man‐Fung Yuen, Vivek A. Saraswat, Gamal Shiha, Osamu Yokosuka, Chandan Kumar Kedarisetty, Priyanka Jain, P. Bhatia, Shiv Kumar Sarin, for the APASL ACLF working party - The American Journal of Gastroenterology 2019 被引用: 83

  15. Combination of Tenofovir Disoproxil Fumarate and Peginterferon α-2a Increases Loss of Hepatitis B Surface Antigen in Patients With Chronic Hepatitis B

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Gastroenterology 2015 被引用: 338

  16. Outcomes of Long-term Treatment of Chronic HBV Infection With Entecavir or Other Agents From a Randomized Trial in 24 Countries

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Tao Han, Yanyan Ji, Junqi Niu, Jian Sun, Yongpeng Chen, Elizabeth Cooney, Seng Gee Lim - Clinical Gastroenterology and Hepatology 2019 被引用: 112

  17. Hepatitis B virus–specific T cells associate with viral control upon nucleos(t)ide-analogue therapy discontinuation

    著者: , , , , , , , , , , , , , , , - Journal of Clinical Investigation 2018 被引用: 209

  18. Asian-Pacific Association for the Study of the Liver (APASL) consensus guidelines on invasive and non-invasive assessment of hepatic fibrosis: a 2016 update

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Hamsik GHaziuan, Nizar N. Zein, Manoj Kumar - Hepatology International 2016 被引用: 235

  19. Therapeutic plasma‐exchange improves systemic inflammation and survival in acute‐on‐chronic liver failure: A propensity‐score matched study from AARC

    著者: , , , , , , , , , , , , , , , , , , , , , , - Liver International 2021 被引用: 59

  20. Phase IIa, randomised, double-blind study of GSK3389404 in patients with chronic hepatitis B on stable nucleos(t)ide therapy

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Melanie Paff, Dickens Theodore - Journal of Hepatology 2022 被引用: 55

  21. Engineering virus-specific T cells that target HBV infected hepatocytes and hepatocellular carcinoma cell lines

    著者: , , , , , , , , , , - Journal of Hepatology 2010 被引用: 214

  22. Analysis and Validation of Human Targets and Treatments Using a Hepatocellular Carcinoma–Immune Humanized Mouse Model

    著者: , , , , , , , , , , , , , , , , - Hepatology 2021 被引用: 50

  23. Switching to or Add-on Peginterferon in Patients on Nucleos(t)ide Analogues for Chronic Hepatitis B: The SWAP RCT

    著者: , , , , , , , , , , , , , , , , - Clinical Gastroenterology and Hepatology 2021 被引用: 47

  24. Global Epidemiology of Cirrhosis: Changing Etiological Basis and Comparable Burden of Nonalcoholic Steatohepatitis between Males and Females

    著者: , , , , , , , , , , , , , , , , , - Digestive Diseases 2023 被引用: 32